Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07B
- Chemical subgroupJ07BBInfluenza vaccines
- Chemical substanceJ07BB02Influenza, purified antigen
Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Quadrivalent influenza vaccine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
33 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Fluad,Fluad Quadrivalent | United States | 60UG/.5ML | Injection | Marketed | Seqirus Inc. |
| Fluarix, Fluarix Quadrivalent | United States | 45UG/.5ML | Injection | Marketed | GlaxoSmithKline Biologicals |
| Flulaval, Flulaval Quadrivalent | United States | 45UG/.5ML | Injection | Marketed | ID Biomedical Corporation of Quebec |
| Flulaval, Flulaval Quadrivalent | United States | 45UG/.5ML | Injection | Marketed | ID Biomedical Corporation of Quebec |
| Flucelvax, Flucelvax Quadrivalent | United States | 45UG/.5ML | Injection | Marketed | Seqirus Inc. |
| Supemtek Tetra (previously Supemtek) | European Union | Authorised | Sanofi Winthrop Industrie | ||
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent | United States | 45UG/.5ML | Injection | Marketed | Sanofi Vaccines US Inc. |
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent | United States | 60UG/.5ML | Injection | Marketed | Sanofi Vaccines US Inc. |
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent | United States | 45UG/.5ML | Injection | Marketed | Sanofi Vaccines US Inc. |
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent | United States | 240UG/.7ML | Injection | Marketed | Sanofi Vaccines US Inc. |
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent | United States | 180 UG/.5ML | Injection | Marketed | Sanofi Vaccines US Inc. |
| Fluzone, Fluzone Hd Quadrivalent, Fluzone High Dose, Fluzone Intradermal, Fluzone Quadrivalent | United States | 60UG/.5ML | Injection | Marketed | Sanofi Vaccines US Inc. |
| Afluria, Afluria Quadrivalent | United States | 30UG/.25ML | Injection | Not marketed | Seqirus Pty Ltd. |
| Afluria, Afluria Quadrivalent | United States | 45UG/.5ML | Injection | Not marketed | Seqirus Pty Ltd. |
| Afluria, Afluria Quadrivalent | United States | 60UG/.5ML | Injection | Not marketed | Seqirus Pty Ltd. |
| Afluria, Afluria Quadrivalent | United States | 225UG | Injection | Not marketed | Seqirus Pty Ltd. |
| Afluria, Afluria Quadrivalent | United States | 60UG/.5ML | Injection | Not marketed | Seqirus Pty Ltd. |
| Fluarix, Fluarix Quadrivalent | United States | 60UG/.5ML | Injection | Not marketed | GlaxoSmithKline Biologicals |
| Flulaval, Flulaval Quadrivalent | United States | 15UG/.5ML | Injection | Not marketed | ID Biomedical Corporation of Quebec |
| Flulaval, Flulaval Quadrivalent | United States | 60UG/.5ML | Injection | Not marketed | ID Biomedical Corporation of Quebec |
| Flulaval, Flulaval Quadrivalent | United States | 60UG/.5ML | Injection | Not marketed | ID Biomedical Corporation of Quebec |
| Fluzone QuadrivalentCombination | Canada | 15 MCG / 0.5 ML + 15 MCG / 0.5 ML + 15 MCG / 0.5 ML + 15 MCG / 0.5 ML | Suspension | Not marketed | Sanofi Vaccines Canada LTD. |
| Flucelvax, Flucelvax Quadrivalent | United States | 60UG/.5ML | Injection | Not marketed | Seqirus Inc. |
| Flucelvax, Flucelvax Quadrivalent | United States | 45UG/.5ML | Injection | Not marketed | Seqirus Inc. |
| Flucelvax, Flucelvax Quadrivalent | United States | 60UG/.5ML | Injection | Not marketed | Seqirus Inc. |